Cargando…
Internet and WeChat used by patients with Crohn’s disease in China: a multi-center questionnaire survey
BACKGROUND: Currently, WeChat is widely used in disease education for patients with Crohn’s disease (CD) in China. It is beneficial for the patients to actively engage in their disease management. METHODS: In this study, we examined the source and expectations of disease information for Chinese CD p...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584988/ https://www.ncbi.nlm.nih.gov/pubmed/31221086 http://dx.doi.org/10.1186/s12876-019-1011-3 |
_version_ | 1783428614069420032 |
---|---|
author | Yu, Qiao Xu, Liyi Li, Lili Zhi, Min Gu, Yubei Wang, Xinying Guo, Hong Li, Yue Fan, Yihong Yang, Bolin Xue, Meng Lv, Minfang Xu, Dingting Zhang, Hanyun Li, Yan Song, Yongmao Deng, Qun Huang, Xiaoxu Zhong, Jing Hu, Wen Zhu, Yimiao Wang, Xiaoying Cai, Jianting Chen, Yan |
author_facet | Yu, Qiao Xu, Liyi Li, Lili Zhi, Min Gu, Yubei Wang, Xinying Guo, Hong Li, Yue Fan, Yihong Yang, Bolin Xue, Meng Lv, Minfang Xu, Dingting Zhang, Hanyun Li, Yan Song, Yongmao Deng, Qun Huang, Xiaoxu Zhong, Jing Hu, Wen Zhu, Yimiao Wang, Xiaoying Cai, Jianting Chen, Yan |
author_sort | Yu, Qiao |
collection | PubMed |
description | BACKGROUND: Currently, WeChat is widely used in disease education for patients with Crohn’s disease (CD) in China. It is beneficial for the patients to actively engage in their disease management. METHODS: In this study, we examined the source and expectations of disease information for Chinese CD patients, analysing the content of popular WeChat public accounts and their potential association with medication adherence. RESULTS: Between November 24th, 2017 and April 10th, 2018, online questionnaires were sent to CD patients from eight different large urban hospitals in China. In all, 436 patients with CD were surveyed, and 342 patients responded. Patients most frequently visited Baidu (65%), WeChat (61%) and medical websites such as Haodaifu (35%) when searching for IBD-related information. Among ten WeChat IBD public accounts, the China Crohn’s and Colitis Foundation (CCCF) (73%), “IBD Academic Officer” (21%) and “IBD in love” (21%) were the most popular. CD patients were most interested in information from the internet about diet and day-to-day health-related living with IBD (83%), an introduction to the disease (80%), and medication advances and side effects (80%). The correlation between the information provided by the top five WeChat public accounts and patients’ expectations was low. Additionally, most patients (64%) had greater confidence in overcoming the disease after learning about CD through their internet searches. Medical adherence was also related to internet access and income (p < 0.05). CONCLUSIONS: WeChat has become a major source of information for IBD education in China, but the content of WeChat didn’t fully meet patients’ expectations. Therefore, future initiatives should aim to provide high-quality information that based on patients’ demands. |
format | Online Article Text |
id | pubmed-6584988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65849882019-06-27 Internet and WeChat used by patients with Crohn’s disease in China: a multi-center questionnaire survey Yu, Qiao Xu, Liyi Li, Lili Zhi, Min Gu, Yubei Wang, Xinying Guo, Hong Li, Yue Fan, Yihong Yang, Bolin Xue, Meng Lv, Minfang Xu, Dingting Zhang, Hanyun Li, Yan Song, Yongmao Deng, Qun Huang, Xiaoxu Zhong, Jing Hu, Wen Zhu, Yimiao Wang, Xiaoying Cai, Jianting Chen, Yan BMC Gastroenterol Research Article BACKGROUND: Currently, WeChat is widely used in disease education for patients with Crohn’s disease (CD) in China. It is beneficial for the patients to actively engage in their disease management. METHODS: In this study, we examined the source and expectations of disease information for Chinese CD patients, analysing the content of popular WeChat public accounts and their potential association with medication adherence. RESULTS: Between November 24th, 2017 and April 10th, 2018, online questionnaires were sent to CD patients from eight different large urban hospitals in China. In all, 436 patients with CD were surveyed, and 342 patients responded. Patients most frequently visited Baidu (65%), WeChat (61%) and medical websites such as Haodaifu (35%) when searching for IBD-related information. Among ten WeChat IBD public accounts, the China Crohn’s and Colitis Foundation (CCCF) (73%), “IBD Academic Officer” (21%) and “IBD in love” (21%) were the most popular. CD patients were most interested in information from the internet about diet and day-to-day health-related living with IBD (83%), an introduction to the disease (80%), and medication advances and side effects (80%). The correlation between the information provided by the top five WeChat public accounts and patients’ expectations was low. Additionally, most patients (64%) had greater confidence in overcoming the disease after learning about CD through their internet searches. Medical adherence was also related to internet access and income (p < 0.05). CONCLUSIONS: WeChat has become a major source of information for IBD education in China, but the content of WeChat didn’t fully meet patients’ expectations. Therefore, future initiatives should aim to provide high-quality information that based on patients’ demands. BioMed Central 2019-06-20 /pmc/articles/PMC6584988/ /pubmed/31221086 http://dx.doi.org/10.1186/s12876-019-1011-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Yu, Qiao Xu, Liyi Li, Lili Zhi, Min Gu, Yubei Wang, Xinying Guo, Hong Li, Yue Fan, Yihong Yang, Bolin Xue, Meng Lv, Minfang Xu, Dingting Zhang, Hanyun Li, Yan Song, Yongmao Deng, Qun Huang, Xiaoxu Zhong, Jing Hu, Wen Zhu, Yimiao Wang, Xiaoying Cai, Jianting Chen, Yan Internet and WeChat used by patients with Crohn’s disease in China: a multi-center questionnaire survey |
title | Internet and WeChat used by patients with Crohn’s disease in China: a multi-center questionnaire survey |
title_full | Internet and WeChat used by patients with Crohn’s disease in China: a multi-center questionnaire survey |
title_fullStr | Internet and WeChat used by patients with Crohn’s disease in China: a multi-center questionnaire survey |
title_full_unstemmed | Internet and WeChat used by patients with Crohn’s disease in China: a multi-center questionnaire survey |
title_short | Internet and WeChat used by patients with Crohn’s disease in China: a multi-center questionnaire survey |
title_sort | internet and wechat used by patients with crohn’s disease in china: a multi-center questionnaire survey |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584988/ https://www.ncbi.nlm.nih.gov/pubmed/31221086 http://dx.doi.org/10.1186/s12876-019-1011-3 |
work_keys_str_mv | AT yuqiao internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT xuliyi internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT lilili internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT zhimin internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT guyubei internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT wangxinying internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT guohong internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT liyue internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT fanyihong internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT yangbolin internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT xuemeng internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT lvminfang internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT xudingting internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT zhanghanyun internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT liyan internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT songyongmao internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT dengqun internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT huangxiaoxu internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT zhongjing internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT huwen internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT zhuyimiao internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT wangxiaoying internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT caijianting internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey AT chenyan internetandwechatusedbypatientswithcrohnsdiseaseinchinaamulticenterquestionnairesurvey |